225 related articles for article (PubMed ID: 23835331)
21. Insulin-like growth factor receptor as a therapeutic target in head and neck cancer.
Barnes CJ; Ohshiro K; Rayala SK; El-Naggar AK; Kumar R
Clin Cancer Res; 2007 Jul; 13(14):4291-9. PubMed ID: 17634559
[TBL] [Abstract][Full Text] [Related]
22. Insulin-sensitizing therapy attenuates type 2 diabetes-mediated mammary tumor progression.
Fierz Y; Novosyadlyy R; Vijayakumar A; Yakar S; LeRoith D
Diabetes; 2010 Mar; 59(3):686-93. PubMed ID: 19959755
[TBL] [Abstract][Full Text] [Related]
23. Characterization of a novel primary mammary tumor cell line reveals that cyclin D1 is regulated by the type I insulin-like growth factor receptor.
Jones RA; Campbell CI; Petrik JJ; Moorehead RA
Mol Cancer Res; 2008 May; 6(5):819-28. PubMed ID: 18505926
[TBL] [Abstract][Full Text] [Related]
24. Tumor necrosis factor-alpha (TNF-alpha) inhibits insulin-like growth factor-I (IGF-I) activities in human trophoblast cell cultures through IGF-I/insulin hybrid receptors.
Hashimoto R; Sakai K; Matsumoto H; Iwashita M
Endocr J; 2010; 57(3):193-200. PubMed ID: 20009360
[TBL] [Abstract][Full Text] [Related]
25. Prolactin enhances insulin-like growth factor I receptor phosphorylation by decreasing its association with the tyrosine phosphatase SHP-2 in MCF-7 breast cancer cells.
Carver KC; Piazza TM; Schuler LA
J Biol Chem; 2010 Mar; 285(11):8003-12. PubMed ID: 20080972
[TBL] [Abstract][Full Text] [Related]
26. Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells.
Song RX; Zhang Z; Chen Y; Bao Y; Santen RJ
Endocrinology; 2007 Aug; 148(8):4091-101. PubMed ID: 17525128
[TBL] [Abstract][Full Text] [Related]
27. Small interfering RNA targeted to IGF-IR delays tumor growth and induces proinflammatory cytokines in a mouse breast cancer model.
Durfort T; Tkach M; Meschaninova MI; Rivas MA; Elizalde PV; Venyaminova AG; Schillaci R; François JC
PLoS One; 2012; 7(1):e29213. PubMed ID: 22235273
[TBL] [Abstract][Full Text] [Related]
28. Highly specific role of the insulin receptor in breast cancer progression.
Rostoker R; Abelson S; Bitton-Worms K; Genkin I; Ben-Shmuel S; Dakwar M; Orr ZS; Caspi A; Tzukerman M; LeRoith D
Endocr Relat Cancer; 2015 Apr; 22(2):145-57. PubMed ID: 25694511
[TBL] [Abstract][Full Text] [Related]
29. Insulin-like growth factor type 1 receptor and insulin receptor isoform expression and signaling in mammary epithelial cells.
Rowzee AM; Ludwig DL; Wood TL
Endocrinology; 2009 Aug; 150(8):3611-9. PubMed ID: 19406949
[TBL] [Abstract][Full Text] [Related]
30. Novel role of cannabinoid receptor 2 in inhibiting EGF/EGFR and IGF-I/IGF-IR pathways in breast cancer.
Elbaz M; Ahirwar D; Ravi J; Nasser MW; Ganju RK
Oncotarget; 2017 May; 8(18):29668-29678. PubMed ID: 27213582
[TBL] [Abstract][Full Text] [Related]
31. Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved.
Pandini G; Frasca F; Mineo R; Sciacca L; Vigneri R; Belfiore A
J Biol Chem; 2002 Oct; 277(42):39684-95. PubMed ID: 12138094
[TBL] [Abstract][Full Text] [Related]
32. EMT reversal in human cancer cells after IR knockdown in hyperinsulinemic mice.
Zelenko Z; Gallagher EJ; Antoniou IM; Sachdev D; Nayak A; Yee D; LeRoith D
Endocr Relat Cancer; 2016 Sep; 23(9):747-58. PubMed ID: 27435064
[TBL] [Abstract][Full Text] [Related]
33. Glucosamine induces resistance to insulin-like growth factor I (IGF-I) and insulin in Hep G2 cell cultures: biological significance of IGF-I/insulin hybrid receptors.
Sakai K; Clemmons DR
Endocrinology; 2003 Jun; 144(6):2388-95. PubMed ID: 12746299
[TBL] [Abstract][Full Text] [Related]
34. In situ phosphorylation of Akt and ERK1/2 in rat mammary gland, colon, and liver following treatment with human insulin and IGF-1.
Hvid H; Fels JJ; Kirk RK; Thorup I; Jensen HE; Hansen BF; Oleksiewicz MB
Toxicol Pathol; 2011 Jun; 39(4):623-40. PubMed ID: 21558470
[TBL] [Abstract][Full Text] [Related]
35. Transgenic IGF-IR overexpression induces mammary tumors with basal-like characteristics, whereas IGF-IR-independent mammary tumors express a claudin-low gene signature.
Franks SE; Campbell CI; Barnett EF; Siwicky MD; Livingstone J; Cory S; Moorehead RA
Oncogene; 2012 Jul; 31(27):3298-309. PubMed ID: 22020329
[TBL] [Abstract][Full Text] [Related]
36. A framework for the in vitro evaluation of cancer-relevant molecular characteristics and mitogenic potency of insulin analogues.
Baricevic I; Jones DR; Roberts DL; Lutzen A; Lundby A; Worm J; Hansen BF; Renehan AG
Carcinogenesis; 2015 Sep; 36(9):1040-50. PubMed ID: 26026165
[TBL] [Abstract][Full Text] [Related]
37. A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor dependent tumor growth in vivo.
Ji QS; Mulvihill MJ; Rosenfeld-Franklin M; Cooke A; Feng L; Mak G; O'Connor M; Yao Y; Pirritt C; Buck E; Eyzaguirre A; Arnold LD; Gibson NW; Pachter JA
Mol Cancer Ther; 2007 Aug; 6(8):2158-67. PubMed ID: 17671083
[TBL] [Abstract][Full Text] [Related]
38. erbB3 recruitment of insulin receptor substrate 1 modulates insulin-like growth factor receptor signalling in oestrogen receptor-positive breast cancer cell lines.
Knowlden JM; Gee JM; Barrow D; Robertson JF; Ellis IO; Nicholson RI; Hutcheson IR
Breast Cancer Res; 2011 Sep; 13(5):R93. PubMed ID: 21939528
[TBL] [Abstract][Full Text] [Related]
39. Growth hormone potentiates 17β-estradiol-dependent breast cancer cell proliferation independently of IGF-I receptor signaling.
Felice DL; El-Shennawy L; Zhao S; Lantvit DL; Shen Q; Unterman TG; Swanson SM; Frasor J
Endocrinology; 2013 Sep; 154(9):3219-27. PubMed ID: 23782942
[TBL] [Abstract][Full Text] [Related]
40. Insulin-like growth factor (IGF) binding protein-3 inhibits type 1 IGF receptor activation independently of its IGF binding affinity.
Ricort JM; Binoux M
Endocrinology; 2001 Jan; 142(1):108-13. PubMed ID: 11145572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
